<DOC>
	<DOCNO>NCT02690935</DOCNO>
	<brief_summary>The primary objective study demonstrate superiority 2L®ALERG placebo term efficacy symptom allergic rhinitis allergic rhinoconjunctivitis patient seasonal allergy grass pollen , correct accord rescue medication intake . The secondary objective compare allergy symptom , rescue medication intake , quality life safety patient treat 2L®ALERG placebo . This multicentre , randomize , double-blind , two-parallel group , interventional placebo-controlled study notify homeopathic medication , market since 2002 . Fifty patient recruit per group achieve 40 case complete per group , i.e. , total 100 patient include 80 case complete . Screening do peak pollination treatment set two month traditional pollen peak , visit 3 month 6 month , end peak . The treatment consist 1 capsule daily , fast morning , follow numerical order 1 10 capsule 6 month . The placebo form , colour , taste aspect . The allowed concomitant treatment already establish treatment associated pathology liable impact proper conduct study rescue medication allow first-line adjuvant treatment ( oral topical antihistamine [ nasal eye ] eye cromoglycate , topical nasal corticosteroid [ case failure insufficiency ] ) . The prohibited treatment oral injectable corticosteroid anti-leukotrienes .</brief_summary>
	<brief_title>Efficacy 2LALERG ( Homeopathic Drug ) Allergic Rhinitis Related Grass Pollen</brief_title>
	<detailed_description>The primary objective study demonstrate superiority 2L®ALERG placebo term efficacy symptom allergic rhinitis allergic rhinoconjunctivitis patient seasonal allergy grass pollen , correct accord rescue medication intake . The secondary objective compare allergy symptom , rescue medication intake , quality life safety patient treat 2L®ALERG placebo . This multicentre , randomize , double-blind , two-parallel group , interventional placebo-controlled study notify homeopathic medication , market since 2002 . Fifty patient recruit per group achieve 40 case complete per group , i.e. , total 100 patient include 80 case complete . Screening do peak pollination treatment set two month traditional pollen peak , visit 3 month 6 month , end peak . The treatment consist 1 capsule daily , fast morning , follow numerical order 1 10 capsule 6 month . The placebo form , colour , taste aspect . The allowed concomitant treatment already establish treatment associated pathology liable impact proper conduct study rescue medication allow first-line adjuvant treatment ( oral topical antihistamine [ nasal eye ] eye cromoglycate , topical nasal corticosteroid [ case failure insufficiency ] ) . The prohibited treatment oral injectable corticosteroid anti-leukotrienes . The following demographic data collect first visit : date birth , gender , ethnic group , weight , height , smoke habit alcohol use status . Medical history , treatment history , concomitant treatment patient 's physical examination also document V0 . The allergy must confirm positive skin test and/or presence IgE grass ( prick test define positive high equal half negative control ; IgE positive least class 3 ( ≥ 3.5 kU / L ) ; test must make late first visit . A patient diary give patient : - For evaluation total 5 symptom score T5SS rescue medication RS , essential patient note every day symptom ( sneeze , rhinorrhoea , nasal pruritus , itch and/or eye tear nasal obstruction ) intensity , rescue medication , patient diary . - It also essential patient take note every day his/her QoL filling three question include his/her diary card : Did sleep well ? - Can work normally ? - How feel ? - It also imperative patient note date start treatment date onset symptom . This patient diary give patient visit , bring back next visit , review validate investigator part Case Report Form . All relevant ( related allergy ) concomitant medication take patient study period record visit CRF . The AEs SAEs record V1 V2 order ass safety .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<criteria>Age ≥18 year , male female Woman childbearing age use effective contraceptive mean Patient faculty understand respect constraint study Symptomatic since least two season confirm positive skin test and/or presence IgE grass ( prick test define positive high equal half negative control ; IgE positive least class 3 ( ≥ 3.5 kU / L ) ; test must perform late first screen visit Signature Informed Consent Form Pregnant woman woman wish become pregnant Breastfeeding woman Patient acute exacerbation allergic rhinitis Patient uncontrolled asthma Immunotherapy receive within last two year Patient know lactose intolerance Patient participate clinical study previous three month Patient sufficiently motivate engage followup period 6 month , unable complete patient diary , likely travel move end study , Patient take nasal bronchial inhaled corticosteroid long term basis ( intermittent consumption season permit provided mention patient 's record )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>grass pollen</keyword>
	<keyword>homeopathy</keyword>
	<keyword>placebo</keyword>
	<keyword>quality life</keyword>
</DOC>